SCHEMBL4191952

SCHEMBL4191952

CS(=O)(=O)Nc1ccc(N2CC(c3ccc(Cl)c(Oc4c(Cl)cccc4C#N)c3)CC2=O)cc1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.37
PDE4B Q07343 3/20 0.37
PDE4C Q08493 3/20 0.37
PDE4D Q08499 3/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PRSS12 P56730 3/20 0.35
SLC22A12 Q96S37 1/20 0.33
EGFR P00533 2/20 0.32
MAPT P10636 2/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009739 0.94 PDE4A (0.35) PDE4APDE4BPDE4CPDE4DSLC6A2
SCHEMBL14035996 0.91 PRSS12 (0.39) PDE4APDE4BPDE4CPDE4DPRSS12
SCHEMBL13923091 0.88 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DPRSS12
SCHEMBL4199728 0.86 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DPRSS12
SCHEMBL4183683 0.86 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DPRSS12
SCHEMBL13922962 0.83 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL14009738 0.83 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DPRSS12
SCHEMBL14009706 0.83 PDE4A (0.34) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL13923089 0.82 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DSLC22A12
SCHEMBL14035891 0.81 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841425-A4 PHENYL-SUBSTITUTED PYRROLIDONES IRM LLC A DELWARE LTD LIABILIT (BM) 2009-02-18 EP disclosed
US-20080287516-A1 Phenyl-Substituted Pyrrolidones IRM LLC (BM) 2008-11-20 US disclosed
EP-1841425-A2 PHENYL-SUBSTITUTED PYRROLIDONES IRM LLC A Delware Limited Liability Company (BM) 2007-10-10 EP disclosed
WO-2006081554-A2 PHENYL-SUBSTITUTED PYRROLIDONES IRM LLC (BM) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287516-A1 Phenyl-Substituted Pyrrolidones MALT1, FKBP5, PREP PDE4A 1181/4885PDE4B 1238/4885PDE4C 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.